Why the study?
Cardiac involvement in idiopathic inflammatory myopathies leads to worse clinical outcomes, but widely available tests such as ECG and echocardiography have limited sensitivity and specificity.
Answers are grounded in this paper and cite their sources.
This review highlights that combining cardiac-specific biomarkers like troponin I with advanced non-invasive imaging, particularly cardiovascular magnetic resonance (CMR) incorporating T1 and T2 mapping, is essential for the early and accurate diagnosis of subclinical myocarditis in patients with idiopathic inflammatory myopathies.
Cardiac involvement in idiopathic inflammatory myopathies (IIM) purports to worse clinical outcomes, and therefore early identification is important. Research has focused on blood biomarkers and basic investigations such as ECG and echocardiography, which have the advantage of wide availability and low cost but are limited in their sensitivity and specificity. Imaging the myocardium to directly look for inflammation and scarring has therefore been explored, with a number of new methods for doing this gaining wider research interest and clinical availability. Cardiovascular magnetic resonance (CMR) with contemporary multiparametric mapping techniques and late gadolinium enhancement imaging, is an extremely valuable and increasingly used non-invasive imaging modality for the diagnosis of myocarditis. The recently updated CMR-based Lake Louise Criteria for the diagnosis of myocarditis incorporate the newer T1 and T2 mapping techniques, which have greatly improved the diagnostic accuracy for IIM myocarditis.18F-FDG-PET/CT is a well-utilized imaging modality in the diagnosis of malignancies in IIM, and it also has a role for the diagnosis of myocarditis in multiple systemic inflammatory diseases. Endomyocardial biopsy, however, remains the gold standard technique for the diagnosis of myocarditis and is necessary for the diagnosis of specific cases of myocarditis. This article provides an overview of the important tests and imaging modalities that clinicians should consider when faced with an IIM patient with potential myocarditis.
No takes yet. Share an insight, caveat, or question.
Sen et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: